Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer

dc.contributor.authorKatsuta, Eriko
dc.contributor.authorYan, Li
dc.contributor.authorOpyrchal, Mateusz
dc.contributor.authorKalinski, Pawel
dc.contributor.authorTakabe, Kazuaki
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2025-04-11T07:50:55Z
dc.date.available2025-04-11T07:50:55Z
dc.date.issued2021-04-05
dc.description.abstractBackground: Cytotoxic T-lymphocyte (CTL) infiltration into tumor is a positive prognostic factor in breast cancer. High tumor mutational burden (TMB) is also considered as a predictor of tumor immunogenicity and response to immunotherapy. However, it is unclear whether the infiltration of functional CTL simply reflects the TMB or represents an independent prognostic value. Methods: Utilizing The Cancer Genome Atlas (TCGA) breast cancer cohort, we established the Functional Hotness Score (FHS). The associations of FHS and breast cancer patient prognosis as well as distinct immunity markers were analyzed in a total of 3011 breast cancer patients using TCGA, METABRIC and metastatic breast cancer (MBC) cohort GSE110590. Results: We established FHS, based on CD8A, GZMB and CXCL10 gene expression levels of bulk tumors, which delivered the best prognostic value among some gene combinations. Breast cancer patients with the high-FHS tumors showed significantly better survival. FHS was lower in the MBCs. Triple-negative breast cancer (TNBC) showed the highest FHS among subtypes. FHS predicted patient survival in hormone receptor (HR)-negative, especially in TNBC, but not in HR-positive breast cancer. FHS predicted patient prognosis independently in TNBC. The high-FHS TNBCs showed not only higher CD8+ T cell infiltration, but also enhanced broader type-1 anti-cancer immunity. The patients with the high-FHS tumors showed better prognosis not only in high-TMB tumors but also in low-TMB TNBCs. The combination of high-TMB with high-FHS identified a unique subset of patients who do not recur over time in TNBC. Conclusion: TNBCs with high FHS based on the expression levels of CD8A, GZMB and CXCL10 showed improved prognosis with enhanced anti-cancer immunity regardless of TMB. FHS constitutes an independent prognostic marker of survival, particularly robustly when combined with TMB in TNBC.
dc.eprint.versionFinal published version
dc.identifier.citationKatsuta E, Yan L, Opyrchal M, Kalinski P, Takabe K. Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer. Ther Adv Med Oncol. 2021;13:17588359211006680. Published 2021 Apr 5. doi:10.1177/17588359211006680
dc.identifier.urihttps://hdl.handle.net/1805/46970
dc.language.isoen_US
dc.publisherSage
dc.relation.isversionof10.1177/17588359211006680
dc.relation.journalTherapeutic Advances in Medical Oncology
dc.rightsAttribution-NonCommercial 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourcePMC
dc.subjectT-cell infiltration
dc.subjectBreast cancer
dc.subjectCytokine profile
dc.subjectTriple-negative breast cancer
dc.subjectTumor microenvironment
dc.subjectTumor mutational burden
dc.titleCytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Katsuta2021Cytotoxic-CCBYNC.pdf
Size:
3.04 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: